Tower Research Capital LLC (TRC) - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 5 filers reported holding AMICUS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$270,450
+71.7%
22,241
+77.3%
0.01%
+60.0%
Q2 2023$157,515
+73162.8%
12,541
-35.3%
0.01%
-28.6%
Q1 2023$215
+481.1%
19,380
+550.3%
0.01%
+250.0%
Q4 2022$37
-100.0%
2,980
-96.6%
0.00%
-86.7%
Q3 2022$921,000
+79.2%
88,209
+84.6%
0.02%
+25.0%
Q2 2022$514,000
+49.9%
47,790
+31.7%
0.01%
+300.0%
Q1 2022$343,000
+40.0%
36,282
+70.8%
0.00%
-25.0%
Q4 2021$245,000
-44.4%
21,248
-54.0%
0.00%
-63.6%
Q3 2021$441,000
+123.9%
46,173
+126.6%
0.01%
+120.0%
Q2 2021$197,000
-31.8%
20,380
-30.5%
0.01%0.0%
Q1 2021$289,000
-50.5%
29,323
+15.9%
0.01%
-72.2%
Q4 2020$584,000
+382.6%
25,308
+195.6%
0.02%
+1700.0%
Q3 2020$121,000
-70.8%
8,562
-68.8%
0.00%
-94.1%
Q2 2020$414,000
+245.0%
27,424
+122.1%
0.02%
+70.0%
Q4 2019$120,000
+11900.0%
12,346
+12246.0%
0.01%
Q3 2019$1,000
-99.4%
100
-99.2%
0.00%
-100.0%
Q3 2018$159,000
+1035.7%
13,192
+1297.5%
0.01%
+500.0%
Q4 2017$14,000
-84.3%
944
-83.9%
0.00%
-71.4%
Q3 2017$89,0005,878
+16694.3%
0.01%
Q2 2017$035
+29.6%
0.00%
Q1 2017$0
-100.0%
27
-98.8%
0.00%
-100.0%
Q4 2016$12,000
-86.4%
2,340
-74.2%
0.00%
-92.9%
Q4 2015$88,000
+57.1%
9,064
+77.7%
0.01%
+100.0%
Q1 2015$56,000
+133.3%
5,102
+27.6%
0.01%
+133.3%
Q3 2014$24,000
+200.0%
4,000
+73.4%
0.00%
+200.0%
Q2 2014$8,0000.0%2,307
-38.3%
0.00%0.0%
Q1 2014$8,000
-20.0%
3,737
-10.9%
0.00%
-50.0%
Q4 2013$10,000
-28.6%
4,193
-31.8%
0.00%0.0%
Q3 2013$14,0006,1510.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 22,790,134$182,777,0006.12%
Perceptive Advisors 24,609,700$197,369,0005.32%
SECTORAL ASSET MANAGEMENT INC 3,441,922$27,604,0004.76%
Palo Alto Investors LP 7,162,920$57,447,0003.83%
Avoro Capital Advisors LLC 11,100,000$89,022,0003.71%
SPHERA FUNDS MANAGEMENT LTD. 2,930,320$23,501,0003.63%
Ghost Tree Capital, LLC 1,705,000$13,674,0003.48%
Novo Holdings A/S 2,317,870$18,589,0003.18%
Copernicus Capital Management, LLC 335,000$2,687,0002.50%
Boxer Capital, LLC 2,325,000$18,647,0001.35%
View complete list of AMICUS THERAPEUTICS INC shareholders